Acorda Therapeutics
ACOR
#10071
Rank
A$1.25 M
Marketcap
$1.01
Share price
0.00%
Change (1 day)
-95.75%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -A$0.41 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are A$0.11 Billion. In 2023 the company made an earning of -A$0.41 Billion a decrease over its 2022 earnings that were of -A$8.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.41 Billion-1.02%
2023 -A$0.41 Billion4848.63%
2022 -A$8.18 Million-93.25%
2021 -A$0.13 Billion2.52%
2020 -A$0.12 Billion-69.45%
2019 -A$0.39 Billion-700.62%
2018 A$64.36 M-118.02%
2017 -A$0.36 Billion805.99%
2016 -A$39.44 Million-173.88%
2015 A$53.37 M-6.58%
2014 A$57.13 M20.19%
2013 A$47.53 M18.7%
2012 A$40.04 M-26.54%
2011 A$54.51 M
2009 -A$0.13 Billion10.65%
2008 -A$0.12 Billion86.17%
2007 -A$60.43 Million68.1%
2006 -A$35.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$32.86 M-107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.59 B-244.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.14 Billion-68.58%๐Ÿ‡ฉ๐Ÿ‡ช Germany
A$95.31 M-122.89%๐Ÿ‡บ๐Ÿ‡ธ USA